Document:

<PAGE>

                                                                    EXHIBIT 4.2

NEITHER THIS WARRANT NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
OR THE SECURITIES LAWS OF ANY STATE.  SUCH SECURITIES MAY NOT BE SOLD OR
OTHERWISE DISPOSED OF UNLESS PURSUANT TO A REGISTERED OFFERING OR BY TRANSFER
EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE
SECURITIES LAWS.

                         ENCHIRA BIOTECHNOLOGY CORPORATION

                            COMMON STOCK PURCHASE WARRANT

No. W-00-______                                                     ______Shares

     This certifies that, for value received, _________________________ or
registered assigns (the "holder"), upon due exercise of this Warrant, is
entitled to purchase from Enchira Biotechnology Corporation, a Delaware
corporation (the "Company"), at any time on or after September 8, 2000 (the
"Initial Exercise Date"), and before the close of business on September 8, 2002,
or if not a trading date on the New York Stock Exchange, the next following
trading date (the "Expiration Date"), all or any part of _______ fully paid and
nonassessable Shares (the "Warrant Shares") of the Common Stock, par value $0.01
per share, of the Company ("Common Stock"), at a purchase price of $7.44 per
share (the "Purchase Price"), both the Purchase Price and the number of Warrant
Shares issuable upon exercise of this Warrant being subject to possible
adjustment as provided below.

     This Warrant is hereinafter called the "Warrant." The holder hereof and
all subsequent holders of this Warrant shall be entitled to all rights and
benefits provided to the holder or holders hereof pursuant to the terms of this
Warrant.

     SECTION 1.  EXERCISE OF WARRANT.  (a) The holder of this Warrant may, at
any time on or after the Initial Exercise Date and on or before the Expiration
Date, exercise this Warrant in whole at any time or in part (but not less than
1,000 Warrant Shares) from time to time for the purchase of the Warrant Shares
or other securities which such holder is then entitled to purchase hereunder
("Warrant Securities") at the Purchase Price (as hereinafter defined).  In order
to exercise this Warrant in whole or in part, the holder hereof shall deliver to
the Company (i) a written notice of such holder's election to exercise this
Warrant, which notice shall specify the number of Warrant Shares to be
purchased, (ii) payment of the aggregate purchase price of the Warrant Shares
being purchased by certified or bank cashier's check, unless pursuant to a
Cashless Exercise as described in subsection (b) below, and (iii) this Warrant,
provided that, if such Warrant Shares or other Warrant Securities have not then
been registered under the Securities Act or applicable state securities laws,
the Company may require that such holder furnish to the Company a written
statement that such holder is purchasing such Warrant Shares or other Warrant
Securities for such holder's own account for investment and not with a view to
the distribution thereof, that none of such shares will be offered or sold in
violation of the provisions of the Securities Act and applicable state
securities laws and as to such other matters relating to the holder as the
Company may reasonably request to permit the issuance of such Warrant Shares or
other Warrant Securities without registration under the Securities Act and
applicable state securities laws.  Upon receipt thereof, the Company shall, as
promptly as practicable, execute or cause to be executed and deliver to such
holder a certificate or certificates representing the aggregate number of
Warrant Shares (or if applicable, other Warrant Securities) specified in said
notice.  The stock certificate or certificates so delivered shall be in the
denomination of 100 shares each or such other denominations

<PAGE>

as may be specified in said notice and shall be registered in the name of
such holder or such other name as shall be designated in said notice.

     No fractional Warrant Shares are to be issued upon the exercise of this
Warrant, but the Company shall pay a cash adjustment in respect of any fraction
of a share which would otherwise be issuable in an amount equal to the same
fraction of the fair market value per share of the Warrant Shares on the day of
exercise, as reasonably determined by the Company consistent with the
determination of "Current Price" below.  If this Warrant shall have been
exercised only in part, the Company shall, at the time of delivery of said
certificate or certificates, deliver to such holder a new Warrant evidencing the
rights of such holder to purchase the remaining Warrant Shares called for by
this Warrant, which new Warrant shall in all other respects be identical with
this Warrant, or, at the request of such holder, appropriate notation may be
made on this Warrant and same returned to such holder.  The Company shall pay
all expenses, taxes and other charges payable in connection with the
preparation, execution and delivery of share certificates under this Section,
except that, if such share certificates are requested to be registered in a name
or names other than the name of the holder of this Warrant, funds sufficient to
pay all stock transfer taxes which shall be payable upon the execution and
delivery of such share certificates shall be paid by the holder hereof at the
time of delivering the notice of exercise mentioned above.

     The Company represents, warrants and agrees that it shall at all times
prior to the exercise of this Warrant reserve sufficient shares of Common Stock
for issuance upon the exercise hereof, and all Warrant Shares issuable upon any
exercise of this Warrant in accordance herewith shall be validly authorized and
issued, fully paid and nonassessable.

     This Warrant shall not entitle the holder hereof to any of the rights of
a stockholder of the Company prior to exercise in the manner herein provided.

     (b)  Notwithstanding anything in subsection (a) to the contrary, the
holder of this Warrant may elect to exercise this Warrant in part (but not for
less than 1,000 Warrant Shares) or in whole, at any time on or after the Initial
Exercise Date and on or before the Expiration Date, by the surrender of this
Warrant (with the cashless exercise form at the end hereof duly executed) (a
"Cashless Exercise") at the address set forth in subsection 6(i) hereof.  Such
presentation and surrender shall be deemed a waiver of the holder's obligation
to pay the Purchase Price, or the proportionate part thereof if this Warrant is
exercised in part.  In the event of a Cashless Exercise, the Holder shall
exchange its Warrant for that number of Warrant Shares or Warrant Securities, as
the case may be, subject to such Cashless Exercise multiplied by a fraction, the
numerator of which shall be the difference between the then Current Market Price
Per Share of the Common Stock and the Per Share Purchase Price, and the
denominator of which shall be the then Current Market Price Per Share of the
Common Stock.  For purposes of any computation under this subsection, the then
Current Market Price shall be based on the trading day prior to the Cashless
Exercise.  "Current Market Price" shall be deemed to be the last sale price of
the Common Stock on the trading day prior to such date or, in case no such
reported sales take place on such day, the average of the last reported bid and
asked prices of the Common Stock on such day, in either case on the principal
national securities exchange on which the Common Stock is admitted to trading or
listed, or if not listed or admitted to trading on any such exchange, the
representative closing bid price of the Common Stock as reported by the National
Association of Securities Dealers, Inc. Automated Quotations System ("NASDAQ"),
or other similar organization if NASDAQ is no longer reporting such information,
or, if the Common Stock is not reported on NASDAQ, the high per share bid price
for the Common Stock in the over-the-counter market as reported by the National
Quotation Bureau or similar organization, or if not so available, the fair

                                     -2-
<PAGE>

market value of the Common Stock as determined in good faith by the Board of
Directors, subject to the right of the holder to contest and appoint an
appraiser to make such determination.

     SECTION 2.  TRANSFER, DIVISION AND COMBINATION.  The Company shall keep
at its principal executive office a register for the registration of, and
registration of transfers of, the Warrants.  The name and address of each holder
of one or more Warrants, each transfer thereof and the name and address of each
transferee of one or more Warrants shall be registered in such register.  Prior
to due presentment for registration of transfer, the person in whose name any
Warrants shall be registered shall be deemed and treated as the owner and holder
thereof for all purposes hereof, and the Company shall not be affected by any
notice or knowledge to the contrary.  The Company shall give to any holder of a
Warrant promptly upon request therefor, a complete and correct copy of the names
and addresses of all registered holders of Warrants.

     Subject to the provisions of Section 3, upon surrender of any Warrant at
the principal executive office of the Company for registration of transfer or
exchange (and in the case of a surrender for registration of transfer, duly
endorsed or accompanied by a written instrument of transfer duly executed by the
registered holder of such Warrant or his attorney duly authorized in writing and
accompanied by the address for notices of each transferee of such Warrant or
part thereof), the Company shall execute and deliver, at the Company's expense,
one or more new Warrants (as requested by the holder thereof) in exchange
therefor, exercisable for an aggregate number of Warrant Shares equal to the
number of shares for which the surrendered Warrant is exercisable and issued to
such person or persons as such holder may request, which Warrant or Warrants
shall in all other respects be identical with this Warrant.

     Upon receipt by the Company of evidence reasonably satisfactory to it of
the ownership of and the loss, theft, destruction or mutilation of any Warrant,
and (a) in the case of loss, theft or destruction, of indemnity reasonably
satisfactory to it (provided that if the holder of such Warrant is, or is a
nominee for, an original holder, such person's own unsecured agreement of
indemnity shall be deemed to be satisfactory), or (b) in the case of mutilation,
upon surrender and cancellation thereof, the Company at its own expense shall
execute and deliver, in lieu thereof, a new Warrant identical in all respects to
such lost, stolen, destroyed or mutilated Warrant.

     SECTION 3.  COMPLIANCE WITH SECURITIES ACT; RESTRICTIONS ON TRANSFER AND
SALE.  (a)   Each certificate for Warrant Shares (or other Warrant Securities)
initially issued upon the exercise of this Warrant and each certificate for
Warrant Shares (or other Warrant Securities) issued to subsequent transferees of
any such certificate shall (unless otherwise permitted by this Section 3) be
stamped or otherwise imprinted with legend in substantially the following form:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR
THE SECURITIES LAWS OF ANY STATE.  SUCH SECURITIES MAY NOT BE SOLD OR
OTHERWISE DISPOSED OF UNLESS PURSUANT TO A REGISTERED OFFERING OR BY
TRANSFER EXEMPT FROM REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE
STATE SECURITIES LAWS."

     (b)  The holder understands that Warrant Shares (or other Warrant
Securities) which may be acquired by it upon exercise of this Warrant shall be
entitled to certain registration rights provided for in the

                                     -3-
<PAGE>

Subscription Agreement relating to the purchase and issuance of the Shares
and this Warrant between the Company and the holder.

     SECTION 4. ADJUSTMENT OF PURCHASE PRICE.

     (a)  The Purchase Price and the number of Warrant Shares and the number
or amount of any other securities and property as hereinafter provided for which
this Warrant may be exercisable shall be subject to adjustment from time to time
effective upon each occurrence of any of the following events.

               (i)    If the Company shall declare or pay any dividend
          with respect to its Common Stock payable in shares of Common
          Stock, subdivide the outstanding Common Stock into a greater
          number of shares of Common Stock, or reduce the number of shares
          of Common Stock outstanding (by stock split, reverse stock split,
          reclassification or otherwise than by repurchase of its Common
          Stock) (any of such events being hereinafter called a "Stock
          Split"), the Purchase Price and number of Warrant Shares issuable
          upon exercise of this Warrant shall be appropriately adjusted so
          as to entitle the holder hereof to receive upon exercise of this
          Warrant, for the same aggregate consideration provided herein, the
          same number of shares of Common Stock (plus cash in lieu of
          fractional shares) as the holder would have received as a result
          of such Stock Split had such holder exercised this Warrant in full
          immediately prior to such Stock Split.

               (ii)   If the Company shall merge or consolidate with or
          into one or more corporations or partnerships and the Company is
          the sole surviving corporation, or the Company shall adopt a plan
          of recapitalization or reorganization in which the Common Stock is
          exchanged for or changed into another class of stock or other
          security or property of the Company, the holder of this Warrant
          shall, for the same aggregate consideration provided herein, be
          entitled upon exercise of this Warrant to receive in lieu of the
          number of shares of Common Stock as to which this Warrant would
          otherwise be exercisable, the number of shares of Common Stock or
          other securities (plus cash in lieu of fractional shares) or
          property to which such holder would have been entitled pursuant to
          the terms of the agreement or plan of merger, consolidation,
          recapitalization or reorganization had such holder exercised this
          Warrant in full immediately prior to such merger, consolidation,
          recapitalization or reorganization.

               (iii)  If the Company is merged or consolidated with or
          into one or more corporations or partnerships under circumstances
          in which the Company is not the sole surviving corporation, or if
          the Company sells or otherwise disposes of substantially all its
          assets, and in connection with any such merger, consolidation or
          sale the holders of Common Stock receive stock or other securities
          convertible into equity of the surviving or acquiring corporations
          or entities, or other securities or property after the effective
          date of such merger, consolidation or sale, as the case may be,
          the holder of this Warrant shall, for the same aggregate
          consideration provided herein, be entitled upon exercise of this
          Warrant to receive, in lieu of the shares of Common Stock as to
          which this Warrant would otherwise be exercisable, shares of such
          stock or other securities (plus cash in lieu of fractional shares)
          or property as the holder of this Warrant would have received
          pursuant to the terms of the merger, consolidation or sale had
          such holder exercised this Warrant in full immediately prior to
          such merger, consolidation or sale.  In the event of any
          consolidation, merger or sale as described in this Section 4(d),
          provision shall be made in connection therewith for the surviving
          or acquiring corporations or partnerships to assume all
          obligations and duties of the

                                     -4-
<PAGE>

          Company hereunder or to issue substitute warrants in lieu of this
          Warrant with all such changes and adjustments in the number or kind
          of shares of stock or securities or property thereafter subject to
          this Warrant or in the Purchase Price as shall be required in
          connection with this Section 4(d).

               (iv)   If the Company (other than in connection with a sale
          described in Section 4(d)) proposes to liquidate and dissolve, the
          Company shall give notice thereof as provided in Section 5(b)
          hereof and shall permit the holder of this Warrant to exercise any
          unexercised portion hereof at any time within the 10 day period
          following delivery of such notice, if such holder should elect to
          do so, and participate as a stockholder of the Company in
          connection with such dissolution.

     (b)  Whenever any adjustment is made as provided in any provision of
this Section 4:

               (i)    the Company shall compute the adjustments in
          accordance with this Section 4 and shall prepare a certificate
          signed by an officer of the Company setting forth the adjusted
          number of shares or other securities or property and Purchase
          Price, as applicable, and showing in reasonable detail the facts
          upon which such adjustment is based, and such certificate shall
          forthwith be filed with the Company or its designee; and

               (ii)   a notice setting forth the adjusted number of shares
          or other securities or property and the Purchase Price, as
          applicable, shall forthwith be required, and as soon as
          practicable after it is prepared, such notice shall be delivered
          by the Company to the holder of record of each Warrant.

     (c)  If at any time, as a result of any adjustment made pursuant to
this Section 4, the holder of this Warrant shall become entitled, upon exercise
hereof, to receive any shares other than shares of Common Stock or to receive
any other securities, the number of such other shares or securities so
receivable upon exercise of this Warrant shall be subject to adjustment from
time to time in a manner and on terms as nearly equivalent as practicable to the
provisions contained in this Section 4 with respect to the Common Stock.

     SECTION 5.  SPECIAL AGREEMENTS OF THE COMPANY.

     (a)  The Company covenants and agrees that it will reserve and set
apart and have at all times a number of shares of authorized but unissued Common
Stock (and, if applicable, other Warrant Securities) then deliverable upon the
exercise of the Warrants or any other rights or privileges provided for therein
sufficient to enable it at any time to fulfill all its obligations thereunder;
and if at any time the number of authorized but unissued shares of Common Stock
shall not be sufficient to effect the exercise of this Warrant at the Purchase
Price then in effect, the Company will take such corporate action as may, in the
reasonable opinion of its counsel, be necessary to increase its authorized
shares but unissued shares of Common Stock (and, if applicable, other Warrant
Securities) to such number of shares as shall be sufficient for such purposes.

     (b)  In case the Company proposes

               (i)    to pay any dividend upon the Common Stock or make
          any distribution or offer any subscription or other rights to the
          holders of Common Stock, or

               (ii)   to effect any capital reorganization or reclassification
          of capital stock of the Company, or

                                     -5-
<PAGE>

               (iii)  to effect the consolidation, merger, sale of all or
          substantially all of the assets, liquidation, dissolution or winding
          up of the Company,

then the Company shall cause notice of any such intended action to be given to
each holder of the Warrants not less than 15 nor more than 60 days prior to the
date on which the transfer books of the Company shall close or a record be taken
for such dividend or distribution, or the date when such capital reorganization,
reclassification, consolidation, merger, sale, liquidation, dissolution or
winding up shall be effected, or the date of such other event, as the case may
be.

     SECTION 6.  NOTICES.  Any notice or other document required or permitted
to be given or delivered to holders of Warrants and holders of Common Stock (or
other Warrant Securities) shall be in writing and sent (a) by telecopy if the
sender on the same day sends a confirming copy of such notice by a recognized
overnight delivery service (charges prepaid), or (b) by registered or certified
mail with return receipt requested (postage prepaid) or (c) by a recognized
overnight delivery service (with charges prepaid).

          (i)  if to the Company, at Enchira Biotechnology Corporation,
     4200 Research Forest Drive, The Woodlands, Texas 77381, Telecopy No.:
     (281) 364-6112, or such other address as it shall have specified to the
     holders of Warrants in writing; or

          (ii) if to a holder, at its address set forth below, or such
     other address as it shall have specified to the Company in writing.

Notices given under this Section 6 shall be deemed given only when actually
received.

     SECTION 7.   AMENDMENT.  This Warrant may not be amended, modified or
otherwise altered in any respect except by the written consent of the registered
holder of this Warrant and the Company.

     SECTION 8.   SUCCESSORS AND ASSIGNS.  This Warrant shall be binding upon
and inure to the benefit of the Company and the holder of this Warrant and their
respective successors and permitted assigns.

     SECTION 9.   GOVERNING LAW.  This Warrant shall be governed by and
construed in accordance with the laws of the State of Delaware, without
reference to the conflicts of law principles thereof.

          IN WITNESS WHEREOF, the Company has caused this Warrant to be
signed in its name by its duly authorized officers and accepted by the holder of
this Warrant this 8th day of September, 2000.

ATTEST:                              ENCHIRA BIOTECHNOLOGY CORPORATION

By:                                  By:
   --------------------------           --------------------------------------
Name:   Paul G. Brown, III               Peter P. Policastro
Title:  Secretary                        President and Chief Executive Officer

Address for Notices:

     -----------------------------

     -----------------------------

                                     -6-
<PAGE>

                                    SUBSCRIPTION

          The undersigned, ___________________, pursuant to the provisions
of the foregoing Warrant, hereby agrees to subscribe for and purchase
____________________ shares of the Common Stock, par value $.01 per share, of
Enchira Biotechnology Corporation covered by said Warrant, and makes payment
therefor in full at the price per share provided by said Warrant.

Dated:                                 Signature:
      ------------------                         ----------------------

Signature Guarantee:                   Address:
                                               ------------------------

                                       Social Security No.
------------------------                                  -------------

                                 CASHLESS EXERCISE

          The undersigned ___________________, pursuant to the provisions of
the foregoing Warrant, hereby elects to exchange its Warrant for
___________________ shares of Common Stock, par value $.01 per share, of Enchira
Biotechnology Corporation pursuant to the Cashless Exercise provisions of the
Warrant.

Dated:                                 Signature:
      ------------------                         ----------------------

Signature Guarantee:                   Address:
                                               ------------------------

                                       Social Security No.
------------------------                                  -------------

                                     ASSIGNMENT

          FOR VALUE RECEIVED _______________ hereby sells, assigns and
transfers unto ____________________ (SS#_________________) the foregoing Warrant
and all rights evidenced thereby, and does irrevocably constitute and appoint
_____________________, attorney, to transfer said Warrant on the books of
Enchira Biotechnology Corporation.

Dated:                                 Signature:
      ------------------                         ----------------------

Signature Guarantee:                   Address:
                                               ------------------------

------------------------

                                     -7-
<PAGE>

                                 PARTIAL ASSIGNMENT

FOR VALUE RECEIVED _______________ hereby assigns and transfers unto
____________________ (SS#________________) the right to purchase _______ shares
of the Common Stock, par value $.01 per share, of Enchira Biotechnology
Corporation covered by the foregoing Warrant, and a proportionate part of said
Warrant and the rights evidenced thereby, and does irrevocably constitute and
appoint ____________________, attorney, to transfer that part of said Warrant on
the books of Enchira Biotechnology Corporation.

Dated:                                 Signature:
      ------------------                         ----------------------

Signature Guarantee:                   Address:
                                               ------------------------

------------------------

                                     -8-<PAGE>

                                                                     EXHIBIT 4.1

     THIS SUPPLEMENTAL INDENTURE is dated as of September 20, 2000 between
Aurora Foods Inc., a Delaware corporation (the "Company"), Sea Coast Foods,
Inc., a Delaware corporation and a subsidiary of the Company (the "Guarantor")
and Wilmington Trust Company, as trustee under the Indenture hereinafter
mentioned (the "Trustee").

     WHEREAS, the Company has heretofore executed and delivered to the Trustee
an indenture dated as of July 1, 1998 (the "Existing Indenture", and the
Existing Indenture, as supplemented by the Supplemental Indenture dated as of
April 1, 1999 among the Trustee, the Guarantor and the Company, and as it may
from time to time be further supplemented or amended by one or more additional
indentures supplemental thereto entered into pursuant to the applicable
provisions thereof, being hereinafter called the "Indenture"), providing for the
creation of and issuance of $200,000,000 in aggregate principal amount of the
Company's 8-3/4% Senior Subordinated Notes due 2008 (the "Notes");

     WHEREAS, the Company and the Guarantor have solicited the consent of the
Holders of the Notes pursuant to a Consent Solicitation Statement dated August
31, 2000 (the "Consent Solicitation Statement") to amend the Indenture to (i)
modify the definitions of "Asset Disposition," "Consolidated Cash Flow,"
"Consolidated Interest Expense," "Refinancing Indebtedness," and "Sale/Leaseback
Transaction" contained in the Indenture, (ii) add a definition of "Consent
Solicitation," "Receivables Purchase Agreement" and "Tennessee Transaction" and
(iii) modify Sections 4.3(b), 4.4(b) and 4.6(a) of the Indenture and (iv) modify
the terms of the Note.

     WHEREAS, pursuant to Section 9.2 of the Indenture, the Company and the
Guarantor may amend or supplement the Indenture provided that the Holders of at
least a majority in principal amount of the Notes then outstanding have
consented;

     WHEREAS, the Company has received the consent of the Holders of a majority
in aggregate principal amount of the Notes to the amendments to the Indenture
set forth in the Consent Solicitation Statement; and

     WHEREAS, immediately upon the execution of this Supplemental Indenture, the
terms hereof will become operative.

     NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH:

     That, for and in consideration of the premises herein contained and in
order to effect the proposed amendments contained in the Consent Solicitation
Statement, pursuant to Section 9.2 of the Indenture, the Company and the
Guarantor agree with the Trustee as follows:
<PAGE>

                                   ARTICLE 1

                             Amendment of Indenture
                             ----------------------

     Section 1.1.  Amendment of Section 1.1.  Pursuant to Section 9.2 of the
Indenture, Section 1.1 of the Indenture is hereby amended by:

(a)  Amending and restating in its entirety the definition of "Asset
Disposition" contained in the Indenture to read as follows:

     "Asset Disposition" means any sale, lease, transfer, issuance or other
disposition (or series of related sales, leases, transfers, issuances or
dispositions that are part of a common plan) of shares of Capital Stock of a
Subsidiary (other than directors' qualifying shares), property or other assets
(each referred to for the purposes of this definition as a "disposition") by the
Company or any of its Subsidiaries (including any disposition by means of a
merger, consolidation or similar transaction) other than (i) a disposition by a
Subsidiary to the Company or a Wholly-Owned Subsidiary or by the Company or a
Subsidiary to a Wholly-Owned Subsidiary, (ii) a disposition of inventory or
Temporary Cash Investments in the ordinary course of business, (iii) a
disposition of obsolete equipment or equipment that is no longer useful in the
conduct of the business of the Company and its Subsidiaries and that is disposed
of in each case in the ordinary course of business, (iv) the sale of other
assets so long as the fair market value of the assets disposed of pursuant to
this clause (iv) does not exceed $2.5 million in the aggregate in any fiscal
year, (v) for the purposes of the covenant described in Section 4.6 only, a
disposition subject to the covenant described in Section 4.4 and (vi) the
disposition of all or substantially all of the assets of the Company in the
manner permitted pursuant to Section 5.1 or any disposition that constitutes a
Change of Control pursuant to this Indenture; provided, however, that for
purposes of this definition, the Tennessee Transaction shall not be considered
an Asset Disposition.

(b)  Adding a definition of "Consent Solicitation" to the Indenture to read as
     follows:

     "Consent Solicitation" means the solicitation commencing in August 2000 by
the Company of consents by holders of the Securities to amendments hereto and
waivers of defaults hereunder in connection with the restatement of the
Company's financial statements in connection with the internal and governmental
investigation of accounting matters commencing February 11, 2000 and related
matters described in the Consent Solicitation Statement of the Company dated
August 31, 2000.

(c)  Amending and restating in its entirety the definition of "Consolidated Cash
     Flow" contained in the Indenture to read as follows:

     "Consolidated Cash Flow" for any period means the Consolidated Net Income
for such period, plus the following to the extent deducted in calculating such
Consolidated Net Income:
<PAGE>

(i) income tax expense, (ii) Consolidated Interest Expense, (iii) depreciation
expense, (iv) amortization expense, in each case for such period, (v) other non-
cash charges reducing Consolidated Net Income (excluding any such non-cash
charge to the extent that it represents an accrual of or reserve for cash
charges in any future period or amortization of a prepaid cash expense that was
paid in a prior period), (vi) for the period ending on the first anniversary of
the Issue Date only, non-recurring relocation and start-up expenses not in
excess of $16.5 million, in each case for such period, and (vii) expenses
relating to (a) the internal and governmental investigation of accounting
matters commencing February 11, 2000, restatement of the Company's financial
statements in connection therewith, the Consent Solicitation and related
matters, including legal, financing and accounting fees and expenses, and
recruiting and relocation expenses for new management in connection with the
foregoing and (b) consolidation of the Company's dry grocery division and San
Francisco operations into the Company's headquarters in St. Louis, and minus, to
the extent not already deducted in calculating Consolidated Net Income, (i) the
aggregate amount of "earnout" payments paid in cash during such period in
connection with acquisitions previously made by the Company and (ii) non-cash
items increasing Consolidated Net Income for such period.

(d)  Amending and Restating in its entirety the definition of "Consolidated
     Interest Expense" contained in the Indenture to read as follows:

     "Consolidated Interest Expense" means, for any period, the total interest
expense of the Company and its Subsidiaries, plus, to the extent not included in
such interest expense, (i) interest expense attributable to Capitalized Lease
Obligations and imputed interest with respect to Attributable Indebtedness, (ii)
amortization of debt discount and debt issuance cost (other than those debt
discounts and debt issuance costs incurred on the Issue Date), (iii) capitalized
interest, (iv) non-cash interest expense, (v) commissions, discounts and other
fees and charges owed with respect to letters of credit and bankers' acceptance
financing, (vi) interest actually paid by the Company or any such Subsidiary
under any Guarantee of Indebtedness or other obligation of any other Person,
(vii) net costs associated with Currency Agreements and Interest Rate Agreements
(including amortization of fees), (viii) the product of (A) all Preferred Stock
dividends in respect of all Preferred Stock of Subsidiaries of the Company and
Disqualified Stock of the Company held by Persons other than the Company or a
Wholly-Owned Subsidiary multiplied by (B) a fraction, the numerator of which is
one and the denominator of which is one minus the then current combined Federal,
state and local statutory tax rate of the Company, expressed as a decimal, in
each case, determined on a consolidated basis in accordance with GAAP and (ix)
the cash contributions to any employee stock ownership plan or similar trust to
the extent such contributions are used by such plan or trust to pay interest or
fees to any Person (other than the Company) in connection with Indebtedness
Incurred by such plan or trust, less any interest expense incurred by the
Company as a result of the Consent Solicitation or the issuance of Common Stock
in connection therewith.

(e)  Adding a definition of "Receivables Purchase Agreement" to the Indenture to
     read as follows:
<PAGE>

     "Receivables Purchase Agreement" means the Receivables Purchase Agreement
dated as of April 19, 2000, as amended, between the Company and The Chase
Manhattan Bank.

(f)  Amending and Restating in its entirety the definition of "Refinancing
     Indebtedness" contained in the Indenture to read as follows:

     "Refinancing Indebtedness" means Indebtedness that is Incurred to refund,
refinance, replace, renew, repay or extend (including pursuant to any defeasance
or discharge mechanism) (collectively, "refinances," and "refinanced" shall have
a correlative meaning) any Indebtedness existing on the date of the Indenture,
existing as of August 15, 2000 or Incurred in compliance with the Indenture
(including Indebtedness of the Company that refinances Indebtedness of any
Subsidiary and Indebtedness of any Subsidiary that refinances Indebtedness of
another Subsidiary) including Indebtedness that refinances Refinancing
Indebtedness, provided, however, that (i) the Refinancing Indebtedness has a
Stated Maturity no earlier than the Stated Maturity of the Indebtedness being
refinanced, (ii) the Refinancing Indebtedness has an Average Life at the time
such Refinancing Indebtedness is Incurred that is equal to or greater than the
Average Life of the Indebtedness being refinanced and (iii) such Refinancing
Indebtedness is Incurred in an aggregate principal amount (or if issued with
original issue discount, an aggregate issue price) that is equal to or less than
the sum of the aggregate principal amount (or if issued with original issue
discount, the aggregate accredited value) then outstanding of the Indebtedness
being refinanced (plus the amount of any premium required to be paid in
connection therewith and plus reasonable fees and expenses in connection
therewith); provided further that Refinancing Indebtedness shall not include
Indebtedness of a Subsidiary which refinances Indebtedness of the Company.

(g)  Amending and Restating in its entirety the definition of "Sale/Leaseback
     Transaction" contained in the Indenture to read as follows:

     "Sale/Leaseback Transaction" means an arrangement relating to the property
now owned or hereafter acquired whereby the Company or a Subsidiary transfers
such property to a Person and the Company or a Subsidiary leases it from such
Person; provided, however, that for purposes of this definition, the Tennessee
Transaction shall not be considered a Sale/Leaseback Transaction.

(h)  Adding a definition of "Tennessee Transaction" to the Indenture to read as
     follows:

     "Tennessee Transaction" means the arrangement between the Company and the
Industrial Development Board of the City of Jackson dated December 31, 1999.

     Section 1.2.  Amendment of Section 4.3.  Pursuant to Section 9.2 of the
Indenture, Section 4.3(b) of the Indenture is hereby amended and restated in its
entirety to read as follows:
<PAGE>

     (b) Notwithstanding Section 4.3(a), the Company and its Subsidiaries may
Incur the following Indebtedness:  (i) Bank Indebtedness provided that the
aggregate principal amount of Indebtedness Incurred pursuant to this clause (i)
does not exceed an amount outstanding at any time equal to $490 million less (x)
the aggregate amount of permanent reductions of commitments to extend credit
thereunder and repayments of principal thereof (without duplication of
repayments required as a result of such reductions of commitments) and (y) any
amounts outstanding under the Receivables Purchase Agreement or similar
arrangement; (ii) Indebtedness (A) of the Company to any Wholly-Owned Subsidiary
and (B) of any Subsidiary to the Company or any Wholly-Owned Subsidiary; (iii)
Indebtedness represented by the Securities, any Indebtedness (other than the
Indebtedness described in clauses (i)-(ii) above) outstanding on August 15, 2000
and any Refinancing Indebtedness Incurred in respect of any Indebtedness
described in this clause (iii) or this paragraph (b); (iv) Indebtedness
represented by the Security Guarantees and Guarantees of Indebtedness Incurred
pursuant to clause (i) above; (v) Indebtedness under Currency Agreements and
Interest Rate Agreements which are entered into for bona fide hedging purposes
of the Company or its Subsidiaries (as determined in good faith by the Board of
Directors or senior management of the Company) and correspond in terms of
notional amount, duration, currencies and interest rates, as applicable, to
Indebtedness of the Company or its Subsidiaries Incurred without violation of
the Indenture or to business transactions of the Company or its Subsidiaries on
customary terms entered into in the ordinary course of business; (vi)
Indebtedness of the Company attributable to Capitalized Lease Obligations, or
Incurred to finance the acquisition, construction or improvement of fixed or
capital assets, or constituting Attributable Indebtedness in respect of
Sale/Leaseback Transactions, in an aggregate principal amount at any one time
outstanding not in excess of $10 million; and (vii) Indebtedness of the Company
or any of its Subsidiaries (which may comprise Bank Indebtedness) in an
aggregate principal amount at any time outstanding not in excess of $15 million.

     Section 1.3.  Amendment of Section 4.4.  Pursuant to Section 9.2 of the
Indenture, Section 4.4(b) of the Indenture is hereby amended and restated in its
entirety to read as follows:

     (b)  The provisions of Section 4.4(a) shall not prohibit:  (i) any purchase
or redemption of Capital Stock or Subordinated Obligations of the Company made
by exchange for, or out of the proceeds of the substantially concurrent sale of,
Capital Stock of the company (other than Disqualified Stock and other than
Capital Stock issued or sold to a Subsidiary or an employee stock ownership plan
or other trust established by the Company or any of its Subsidiaries); provided,
however, that (A) such purchase or redemption shall be excluded in the
calculation of the amount of Restricted Payments and (B) the Net Cash Proceeds
from such sale shall be excluded from clause Section 4.4(a)(3)(B); (ii) any
purchase or redemption of Subordinated Obligations of the Company made by
exchange for, or out of the proceeds of the substantially concurrent sale of,
Subordinated Obligations of the Company; provided, however, that such purchase
or redemption shall be excluded in the calculation of the amount of Restricted
Payments; (iii) any purchase or redemption of Subordinated Obligations from Net
Available Cash to the extent permitted under Section 4.6; provided, however,
that such purchase or
<PAGE>

redemption shall be excluded in the calculation of the amount of Restricted
Payments; (iv) dividends paid within 60 days after the date of declaration if at
such date of declaration such dividend would have complied with this provision;
provided, however, that such dividend shall be included in the calculation of
the amount of Restricted Payments; (v) amounts expended by the Company to
repurchase Capital Stock of the Company owned by employees (including former
employees) of the Company or its Subsidiaries or their assigns, estates and
heirs; provided that the aggregate amount paid, loaned or advanced pursuant to
this clause (v) shall not, in the aggregate, exceed the sum of $5.0 million plus
any amounts received by the Company as a result of resales of such repurchased
shares of Capital Stock; (vi) any repurchase of equity interest deemed to occur
upon exercise of stock options if such equity interests represent a portion of
the exercise price of such options; or (vii) any distribution or payment in
connection with the Tennessee Transaction.

     Section 1.4.  Amendment of Section 4.6.  Pursuant to Section 9.2 of the
Indenture, Section 4.6(a) of the Indenture is hereby amended and restated in its
entirety to read as follows:

     (a)  The Company shall not, and shall not permit any Subsidiary to, make
any Asset Disposition unless (i) the Company or such Subsidiary receives
consideration (including by way of relief from, or by any other Person assuming
sole responsibility for, any liabilities, contingent or otherwise) at the time
of such Asset Disposition at least equal to the fair market value of the shares
and assets subject to such Asset Disposition, (ii) at least 85% of the
consideration thereof received by the Company or such Subsidiary is in the form
of cash and (iii) an amount equal to 100% of the Net Available Cash from Asset
Disposition is applied by the Company (or such Subsidiary, as the case may be)
(A) first, to the extent the Company elects (or is required by the terms of any
Senior Indebtedness or Indebtedness (other than Preferred Stock) of a Wholly-
Owned Subsidiary), to prepay, repay or purchase Senior Indebtedness or such
Indebtedness (other than Preferred Stock) of a Wholly-Owned Subsidiary (in each
case other than Indebtedness owed to the Company or an Affiliate of the Company)
within one year after the later of the date of such Asset Disposition or the
receipt of such Net Available Cash; (B) second, to the extent of the balance of
Net Available Cash after application in accordance with clause (A), to the
extent the Company or such Subsidiary elects, to reinvest in Additional Assets
(including by means of an Investment in Additional Assets by a Subsidiary with
Net Available Cash received by the Company or another subsidiary) within one
year after the later of the date of such Asset Disposition or the receipt of
such Net Available Cash; (C) third, to the extent of the balance of such Net
Available Cash after application in accordance with clauses (A) and (B), to make
an offer to purchase the Existing Notes pursuant and subject to the conditions
of the Existing Indentures to the holders thereof at a purchase price of 100% of
the principal amount thereof plus accrued and unpaid interest to the purchase
date; (D) fourth, to the extent of the balance of such Net Available Cash after
application in accordance with clauses (A), (B) and (C), to make an offer to
purchase the Notes and other Subordinated Indebtedness (other than the Existing
Notes) at the time outstanding with similar provisions requiring the Company to
make an offer to purchase such Indebtedness with the proceeds from any Asset
Disposition ("Pari Passu Notes") at 100% of the principal amount thereof (or
100% of the accredited value of such Pari Passu Notes if such
<PAGE>

Pari Passu Notes were issued at a discount) plus accrued and unpaid interest, if
any, to the date of purchase; and (E) fifth, to the extent of the balance of
such Net Available Cash after application in accordance with clauses (A), (B),
(C) and (D), to (x) acquire Additional Assets (other than Indebtedness and
Capital Stock) or (y) prepay, repay or purchase Indebtedness of the Company
(other than Indebtedness owed to an Affiliate of the Company and other than
Disqualified Stock of the Company) or Indebtedness of any Subsidiary (other than
Indebtedness owed to the Company or an Affiliate of the Company), in each case
described in this clause (E) within one year from the receipt of such Net
Available Cash or, if the Company has made an Offer pursuant to Clause (D), six
months from the date such Offer is consummated; provided, however, that, in
connection with any prepayment, repayment or purchase of Indebtedness pursuant
to clause (A), (C), (D) or (E) above, the Company or such Subsidiary shall
retire such Indebtedness and shall cause the related loan commitment (if any) to
be permanently reduced in an amount equal to the principal amount so prepaid,
repaid or repurchased. Notwithstanding the foregoing provisions, the
consideration received by the Company and any Subsidiary in connection with the
Asset Dispositions under the Receivables Purchase Agreement shall not be subject
to clause (iii) of the preceding sentence and shall not constitute Net Available
Cash. Notwithstanding the foregoing provisions, the Company and its Subsidiaries
shall not be required to apply any Net Available Cash in accordance herewith
except to the extent that the aggregate Net Available Cash from all Asset
Dispositions which are not applied in accordance with this Section 4.6 at any
time exceed $5.0. The Company shall not be required to make an offer for
Securities and Pari Passu Notes pursuant to this covenant if the Net Available
Cash available therefor (after application of the proceeds as provided in
clauses (A), (B) and (C)) is less than $10.0 million for any particular Asset
Disposition (which lesser amounts shall be carried forward for purposes of
determining whether an offer is required with respect to the Net Available Cash
from any subsequent Asset Disposition).

     For the purposes of this Section 4.6, the following will be deemed to be
cash:  (x) the assumption of Indebtedness (other than Disqualified Stock) of the
Company or any Subsidiary and the release of the Company or such Subsidiary from
all liability on such Indebtedness in connection with such Asset Disposition and
(y) securities received by the Company or any Subsidiary of the Company from the
transferee that are promptly converted by the Company or such Subsidiary into
cash.

     Section 1.5.  Amendment of Exhibit A and B.  Pursuant to Section 9.2 of the
Indenture, Paragraph 2 of Section 5 of the Forms of Notes appended to the
Indenture as Exhibit A and Exhibit B is hereby amended and restated to read as
follows:

     Year                                     Redemption Price
     ----                                     ----------------

     2003....................................... 106.375%
     2004....................................... 104.917%
     2005....................................... 103.458%
     2006 and thereafter........................ 102.000%
<PAGE>

                                   ARTICLE 2

                                  The Trustee
                                  -----------

     Section 2.1.  Privileges and Immunities of Trustee.  The Trustee accepts
the amendment of the Indenture effected by this Supplemental Indenture but only
upon the terms and conditions set forth in the Indenture, including the terms
and provisions defining and limiting the liabilities and responsibilities of the
Trustee, which terms and provisions shall in like manner define and limit its
liabilities and responsibilities in the performance of the trust created by the
Indenture as hereby amended.  The Trustee shall not be responsible for the
adequacy or sufficiency of the Supplemental Indenture, for the due execution
thereof by the Company or for the recitals contained herein, which are the
Company's responsibilities.

                                   ARTICLE 3

                            Miscellaneous Provisions
                            ------------------------

     Section 3.1.  Instruments to be Read Together.  This Supplemental Indenture
is an indenture supplemental to and in implementation of the Indenture, and said
Indenture and this Supplemental Indenture shall henceforth be read together.

     Section 3.2.  Confirmation.  The Indenture as amended and supplemented by
this Supplemental Indenture is in all respects confirmed and preserved.

     Section 3.3.  Terms Defined.  Capitalized terms used herein without
definition shall have the meanings assigned to them in the Indenture.

     Section 3.4.  Counterparts.  This Supplemental Indenture may be signed in
any number of counterparts each of which so executed shall be deemed to be an
original, but all such counterparts shall together constitute but one and the
same instrument.

     Section 3.5.  Effectiveness.  The provisions of this Supplemental Indenture
will take effect immediately upon execution thereof by the parties hereto.

     Section 3.6.  Governing Law.  The internal law of the State of New York
shall govern and be used to construe this Supplemental Indenture.  This
Supplemental Indenture is subject to the
<PAGE>

provisions of the Trust Indenture Act that are required to be part of the
Indenture and shall, to the extent applicable, be governed by such provisions.

              [Remainder of this page intentionally left blank.]
<PAGE>

     IN WITNESS WHEREOF, the parties hereto have caused this Supplemental
Indenture to be duly executed as of the date first above written.

                              AURORA FOODS INC.

                              By: /s/ Christopher T. Sortwell
                                  ---------------------------
                              Name:  Christopher T. Sortwell
                              Title: Chief Financial Officer,
                                      Secretary and Executive Vice President

                              SEA COAST FOODS, INC.

                              By: /s/ Christopher T. Sortwell
                                  ---------------------------
                              Name:  Christopher T. Sortwell
                              Title: Chief Financial Officer and Secretary

                              WILMINGTON TRUST COMPANY, AS TRUSTEE

                              By: /s/ Bruce L. Bisson
                                  -------------------
                              Name:  Bruce L. Bisson
                              Title: Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00015-of-00352.parquet"}]]